Updated UK Recommendations for HER2 assessment in breast cancer

A. Rakha, Emad; E. Pinder, Sarah; M.S. Bartlett, John; Ibrahim, Merdol; Starczynski, Jane; J Carder, P; Provenzano, Elena; M. Hanby, Andrew; Hales, S; H.S. Lee, Andrew; O. Ellis, Ian

doi:10.1136/jclinpath-2014-202571

Public

Updated UK Recommendations for HER2 assessment in breast cancer

Published in Journal of Clinical Pathology • Dec 8, 2014

Authors:

Emad A. Rakha

Sarah E. Pinder

John M.S. Bartlett

Abstract

Human epidermal growth factor receptor 2 (HER2) overexpression is present in approximately 15% of early invasive breast cancers, and is an important predictive and prognostic marker. The substantial benefits achieved with anti-HER2 targeted therapies in patients with HER2-positive breast cancer have...

Subject

Breast cancer

Medicine

Bioinformatics

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!